Predicting the Cost and Pace of Pharmacogenomic Advances: An Evidence-Based Study
Predicting the cost and pace of pharmacogenomic advances: An evidence-based study
Ramy Arnaout, Thomas P. Buck, Paulvalery Roulette,and Vikas P. Sukhatme 2013 Clinical Chemistry 59:4
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario